Finer markers, such as neutrophil gelatinase-associated lipocalin (NGAL), cystatin-C, interleukin-18, or beta-2 microglobulin may be needed to allow earlier and more accurate detection of CA-AKI (103). The gene discussed is B2M; the disease is acute kidney injury.